Literature DB >> 17476477

[Imaging of avascular necrosis of the femoral head in adults].

S Reppenhagen1, W Kenn, J Reichert, P Raab, J Eulert, U Nöth.   

Abstract

The aim of diagnostic imaging procedures in avascular femoral head necrosis is to provide the patient with a stage-adapted therapy. Therefore, a differentiated diagnostic work-up is needed. Native radiography of the hip in two planes is still the first step. Over the past years, the diagnosis of femoral head necrosis has experienced tremendous improvement due to the use of MRI and CT scans. Because of these improvements the correct stage can be diagnosed early and the appropriate therapy can be initiated immediately. Today, MRI is the most sensitive diagnostic imaging procedure. CT scans can be particularly useful to exclude subchondral fractures. The use of bone scintigraphy is restricted to exceptional cases. In Europe, the ARCO classification of avascular femoral head necrosis has been widely accepted. It is essential here to define subtypes according to the localisation and the extent of the necrosis, because both have major influence on the prognosis of the disease and therefore also for the therapeutic strategy. In this overview, we describe the specific characteristics of the different diagnostic imaging procedures and illustrate them with appropriate imaging material. At the end of the article an algorithm for diagnostic imaging procedures in avascular femoral head necrosis for daily orthopaedic practice is proposed.

Entities:  

Mesh:

Year:  2007        PMID: 17476477     DOI: 10.1007/s00132-007-1090-7

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  26 in total

1.  Transient bone marrow edema syndrome progressing to avascular necrosis of the hip - a case report and review of the literature.

Authors:  S Radke; W Kenn; J Eulert
Journal:  Clin Rheumatol       Date:  2003-12-19       Impact factor: 2.980

Review 2.  Imaging of avascular necrosis of bone.

Authors:  H Imhof; M Breitenseher; S Trattnig; J Kramer; S Hofmann; H Plenk; W Schneider; A Engel
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

3.  Femoral head osteonecrosis. Detection by magnetic resonance imaging versus single-photon emission computed tomography.

Authors:  I L Miller; C G Savory; D W Polly; G D Graham; J M McCabe; J J Callaghan
Journal:  Clin Orthop Relat Res       Date:  1989-10       Impact factor: 4.176

Review 4.  Distinguishing transient osteoporosis from avascular necrosis of the hip.

Authors:  J J Guerra; M E Steinberg
Journal:  J Bone Joint Surg Am       Date:  1995-04       Impact factor: 5.284

5.  CT analysis of the upper end of the femur: the asterisk sign and ischaemic bone necrosis of the femoral head.

Authors:  W Dihlmann
Journal:  Skeletal Radiol       Date:  1982       Impact factor: 2.199

6.  [The asterisk sign and adult ischemic femur head necrosis].

Authors:  W Dihlmann; M Heller
Journal:  Rofo       Date:  1985-04

7.  [Reproducibility of radiological classification criteria of femur head necrosis].

Authors:  J Stöve; F Riederle; S Kessler; W Puhl; K P Günther
Journal:  Z Orthop Ihre Grenzgeb       Date:  2001 Mar-Apr

Review 8.  Systematic analysis of classification systems for osteonecrosis of the femoral head.

Authors:  Michael A Mont; German A Marulanda; Lynne C Jones; Khaled J Saleh; Noah Gordon; David S Hungerford; Marvin E Steinberg
Journal:  J Bone Joint Surg Am       Date:  2006-11       Impact factor: 5.284

Review 9.  [Osteonecrosis of the hip joint in adulthood].

Authors:  S Hofmann; J Kramer; H Plenk
Journal:  Radiologe       Date:  2002-06       Impact factor: 0.635

10.  Distinguishing transient osteoporosis of the hip from avascular necrosis.

Authors:  Anita Balakrishnan; Emil H Schemitsch; Dawn Pearce; Michael D McKee
Journal:  Can J Surg       Date:  2003-06       Impact factor: 2.089

View more
  1 in total

1.  [Bone marrow edema syndrome (BMES)].

Authors:  B S Craiovan; C Baier; J Grifka; J Götz; J Schaumburger; J Beckmann
Journal:  Orthopade       Date:  2013-03       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.